Literature DB >> 10024114

Perioperative growth hormone treatment and functional outcome after major abdominal surgery: a randomized, double-blind, controlled study.

P Kissmeyer-Nielsen1, M B Jensen, S Laurberg.   

Abstract

OBJECTIVE: To evaluate short- and long-term effects of perioperative human growth hormone (hGH) treatment on physical performance and fatigue in younger patients undergoing a major abdominal operation in a normal postoperative regimen with oral nutrition. SUMMARY BACKGROUND DATA: Muscle wasting and functional impairment follow major abdominal surgery.
METHODS: Twenty-four patients with ulcerative colitis undergoing ileoanal J-pouch surgery were randomized to hGH (12 IU/day) or placebo treatment from 2 days before to 7 days after surgery. Measurements were performed 2 days before and 10, 30, and 90 days after surgery.
RESULTS: The total muscle strength of four limb muscle groups was reduced by 7.6% in the hGH group and by 17.1% in the placebo group at postoperative day 10 compared with baseline values. There was also a significant difference between treatment groups in total muscle strength at day 30, and at the 90-day follow-up total muscle strength was equal to baseline values in the hGH group, but still significantly 5.9% below in the placebo group. The work capacity decreased by approximately 20% at day 10 after surgery, with no significant difference between treatment groups. Both groups were equally fatigued at day 10 after surgery, but at day 30 and 90 the hGH patients were less fatigued than the placebo patients. During the treatment period, patients receiving hGH had reduced loss of limb lean tissue mass, and 3 months after surgery the hGH patients had regained more lean tissue mass than placebo patients.
CONCLUSIONS: Perioperative hGH treatment of younger patients undergoing major abdominal surgery preserved limb lean tissue mass, increased postoperative muscular strength, and reduced long-term postoperative fatigue.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10024114      PMCID: PMC1191645          DOI: 10.1097/00000658-199902000-00020

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  24 in total

1.  Urinary excretion and efflux from the leg of 3-methylhistidine before and after major surgical operation.

Authors:  M J Rennie; K Bennegård; E Edén; P W Emery; K Lundholm
Journal:  Metabolism       Date:  1984-03       Impact factor: 8.694

2.  Skeletal muscle function in malnutrition.

Authors:  J Lopes; D M Russell; J Whitwell; K N Jeejeebhoy
Journal:  Am J Clin Nutr       Date:  1982-10       Impact factor: 7.045

3.  Growth hormone improves muscle protein metabolism and whole body nitrogen economy in man during a hyponitrogenous diet.

Authors:  S Lundeberg; M Belfrage; J Wernerman; A von der Decken; S Thunell; E Vinnars
Journal:  Metabolism       Date:  1991-03       Impact factor: 8.694

4.  Nitrogen retention caused by growth hormone in patients undergoing gastrointestinal surgery with epidural analgesia and parenteral nutrition.

Authors:  M Mjaaland; K Unneberg; R Hotvedt; A Revhaug
Journal:  Eur J Surg       Date:  1991-01

5.  Changes in cardiorespiratory and muscle function associated with the development of postoperative fatigue.

Authors:  M R Zeiderman; E A Welchew; R G Clark
Journal:  Br J Surg       Date:  1990-05       Impact factor: 6.939

6.  Nutritional and hormonal effects of biosynthetic human growth hormone in surgical patients on total parenteral nutrition.

Authors:  D Piccolboni; L de Vincentiis; G Guerriero; A Belli; L Romano; S Zofra; A Maglione; E de Vincentiis
Journal:  Nutrition       Date:  1991 May-Jun       Impact factor: 4.008

7.  Fatigue and cardiorespiratory function following abdominal surgery.

Authors:  T Christensen; T Bendix; H Kehlet
Journal:  Br J Surg       Date:  1982-07       Impact factor: 6.939

Review 8.  Nutritional support in inflammatory bowel disease: current status and future directions.

Authors:  G R Greenberg
Journal:  Scand J Gastroenterol Suppl       Date:  1992

9.  Protein and energy metabolism with biosynthetic human growth hormone after gastrointestinal surgery.

Authors:  H C Ward; D Halliday; A J Sim
Journal:  Ann Surg       Date:  1987-07       Impact factor: 12.969

10.  Postoperative positive nitrogen balance with intravenous hyponutrition and growth hormone.

Authors:  G A Ponting; D Halliday; J D Teale; A J Sim
Journal:  Lancet       Date:  1988-02-27       Impact factor: 79.321

View more
  7 in total

1.  Effects of short-term application of low-dose growth hormone on trace element metabolism and blood glucose in surgical patients.

Authors:  Kun Qian; Zhi Wan; Lang-Song Hao; Ming-Ming Zhang; Yong Zhou; Xiao-Ting Wu
Journal:  World J Gastroenterol       Date:  2007-12-14       Impact factor: 5.742

Review 2.  Postoperative fatigue: a review.

Authors:  Kamran Zargar-Shoshtari; Andrew G Hill
Journal:  World J Surg       Date:  2009-04       Impact factor: 3.352

3.  Clinical evidence of growth hormone for patients undergoing abdominal surgery: meta-analysis of randomized controlled trials.

Authors:  Yong Zhou; Xiao-Ting Wu; Gang Yang; Wen Zhuang; Mao-Ling Wei
Journal:  World J Gastroenterol       Date:  2005-07-07       Impact factor: 5.742

4.  Short-term application of low-dose growth hormone in surgical patients: effects on nitrogen balance and blood glucose.

Authors:  Ming-Ming Zhang; Xiao-Ting Wu; Yong Zhou; Kun Qian; Ya-Min Zheng
Journal:  World J Gastroenterol       Date:  2007-01-21       Impact factor: 5.742

Review 5.  Justified and unjustified use of growth hormone.

Authors:  A J van der Lely
Journal:  Postgrad Med J       Date:  2004-10       Impact factor: 2.401

6.  Activation of the dopamine 1 and dopamine 5 receptors increase skeletal muscle mass and force production under non-atrophying and atrophying conditions.

Authors:  Deborah L Reichart; Richard T Hinkle; Frank R Lefever; Elizabeth T Dolan; Jeffrey A Dietrich; David R Sibley; Robert J Isfort
Journal:  BMC Musculoskelet Disord       Date:  2011-01-26       Impact factor: 2.362

Review 7.  Growth Hormone Resistance-Special Focus on Inflammatory Bowel Disease.

Authors:  Christoffer Soendergaard; Jonathan A Young; John J Kopchick
Journal:  Int J Mol Sci       Date:  2017-05-09       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.